Commentary Open Access
Volume 2 | Issue 1 | DOI: https://doi.org/10.46439/anesthesia.2.007
Drug delivery via the upper nasal space: A novel route for anesthesiologists, intensivists and emergency department physicians?
Stephen Shrewsbury1.*, Jasna Hocevar-Trnka1, John Hoekman1
- 1Impel NeuroPharma Inc., Seattle, WA, USA
Corresponding Author
Stephen Shrewsbury, sshrewsbury@impelnp.com
Received Date: December 11, 2020
Accepted Date: February 19, 2021
Shrewsbury S, Hocevar-Trnka J, Hoekman J. Drug delivery via the upper nasal space: A novel route for anesthesiologists, intensivists and emergency department physicians? J Clin Anesth Intensive Care. 2021; 2(1): 8-14.
Copyright: © 2021 Shrewsbury S, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Keywords
Upper nasal delivery, Olanzapine, Precision Olfactory Delivery
Recommended Articles
Drug delivery via the upper nasal space: A novel route for anesthesiologists, intensivists and emergency department physicians?
Many drugs are effective systemically, but slow onset of non-intravenous routes of administration may limit their clinical utility. While anesthesiologists usually have intravenous (IV) access for drug delivery, other healthcare professionals in less controlled situations such as acute crises in the emergency room, critical care settings, or urgent needs in the community, may need non-invasive drug delivery [1].
Dynamics of the ‘free’ maternal healthcare policy intervention in Ghana; Facility delivery utilization and neonatal mortality indices from a developing country setting
The one conceptual key to improving newborn healthcare outcomes is thought to be bridging the access gap to care, particularly in sub-Saharan Africa. However, recent studies have reported conflicting results relative to establishing a link between outcomes and access to care intervention programs.
Nanoparticle-based drug delivery systems: Unveiling the immunological implications
As the field of immunology continues to unravel the complexities of immune responses and their intersection with therapeutic interventions, the emergence of innovative drug delivery systems has sparked new avenues of exploration. The original research on FericipXT-coated PEGylated rutile TiO2 nanoparticles (NPs) in drug delivery has not only illuminated the realm of pharmaceutical science but also beckons the attention of immunologists, offering profound insights into the immunological implications of nanoparticle-based drug delivery systems.
Aiming for the brain: a new thermogel-based drug delivery platform
The design of safe drug delivery systems that locally allow efficacious concentration of curative molecules has become the latest frontier in nanomedicine. It usually relies on the entrapment of drugs into micro/nano carriers guaranteeing for the controlled release of the drugs while protecting them from degradation and fast clearance.
Injectable hydrogel of biopolymers as controlled drug-delivery vehicle for melanoma treatment: A commentary
Melanoma is a strongly incursive cancer situated in the skin with narrow consecutive therapies. The goal of this article is to reveal some of the latest advances in using hydrogel for cancer especially melanoma therapy. Biocompatible brush biopolymer (linear dextrin) graft with polyurethane is developed for monitoring the hydrophilic and hydrophobic equipoise for regulating the delivery of drug to the target region. Drug incorporated brush copolymers upon embedded in gelating agent (methyl cellulose) develop an injectable hydrogel with potential